Articles / Discussing MDMA
writer
Sessional Lecturer, RMIT University | Professor at the National Drug Research Institute (Melbourne), Curtin University | Sessional psychology lecturer, Australian Catholic University
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
We all want to reduce drug-related harm and ensure young people don’t take unnecessary risks. But decades of research shows fear isn’t an effective way to do this.
This week, Newscorp Australia released The Ripple Effect, a series of articles and accompanying videos about party drugs, aimed at parents of young people.
Rather than drawing on the science about reducing harm, the series overstates the nation’s drug problem and the likelihood of problems from taking MDMA (ecstasy). And it’s likely to scare the wits out of parents of teens.
So, what do parents really need to know about party drugs?
Illicit drug use among teens is low and has been in decline for nearly a decade.
Although Australians overall have a relatively high rate of MDMA use compared to similar countries, only a small proportion of teenagers (around 3%) and young adults (7%) have used MDMA in the last year. Among high school students, the overwhelming majority (94%) have never tried MDMA.
Normalising the idea that drug use isn’t that common is a key prevention strategy in drug education. If young people think “everyone” is using drugs, they are more likely to want to do it too.
Menopausal Hormone Therapy - What Dose of Estrogen is Best?
Cardiovascular Benefits of GLP1s – New Evidence
Oral Contraceptive Pill in Teens
RSV and the Heart
writer
Sessional Lecturer, RMIT University | Professor at the National Drug Research Institute (Melbourne), Curtin University | Sessional psychology lecturer, Australian Catholic University
Modified but kept in place
Eliminated entirely without replacement
Maintained as is
Completely replaced with an alternative system
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease